long-term safety of momelotinib for myelofibrosis
Published 4 years ago • 103 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
2:53
long-term safety of momelotinib in myelofibrosis: pooled data from three phase iii randomized trials
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:20
safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
4:14
long-term safety and efficacy of sutimlimab for chronic itp
-
4:10
the management of prefibrotic myelofibrosis
-
14:38
hematology in 10 min hemostasis and coagulation mp4 final
-
3:01
updates from the bruin study – long-term safety of pirtobrutinib in r/r mcl
-
1:40
momelotinib for the treatment of myelofibrosis
-
3:02
latest updates on momelotinib: safety, durability of response & survival benefit
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
1:52
maic of momelotinib versus fedratinib safety in myelofibrosis
-
2:28
long-term momelotinib exposure in jaki-naïve or previously jaki-treated myelofibrosis patients
-
1:28
indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis
-
4:07
safety of full dose pacritinib versus bat in patients with cytopenic myelofibrosis
-
4:25
update on momelotinib for myelofibrosis
-
0:46
safety of treating myelofibrosis with ruxolitinib – results from jump trial
-
1:24
the long-term safety and efficacy of ibrutinib monotherapy in patients with previously-treated wm
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent